Acute urticaria with Angioedema in a patient with COVID-19 pneumonia: Favipiravir side effect or a rare cutaneous manifestation

Basit Öğe Kaydı
dc.authorid0000-0003-1944-2477en_US
dc.authorid-en_US
dc.authorid-en_US
dc.authorid-en_US
dc.authorid-en_US
dc.authorid-en_US
dc.authorid0000-0002-8403-8430en_US
dc.authorscopusid57526218800en_US
dc.authorscopusid23996235800en_US
dc.authorscopusid57473608100en_US
dc.authorscopusid-en_US
dc.authorscopusid57417317400en_US
dc.authorscopusid57244436000en_US
dc.authorscopusid57225036974en_US
dc.authorwosidABH-8663-2020en_US
dc.authorwosid-en_US
dc.authorwosid-en_US
dc.authorwosid-en_US
dc.authorwosid-en_US
dc.authorwosid-en_US
dc.authorwosid-en_US
dc.contributor.authorÇeviker, Sevil Alkan
dc.contributor.authorŞener, Alper
dc.contributor.authorYüksel, Cihan
dc.contributor.authorÖnder, Taylan
dc.contributor.authorAkça, Anıl
dc.contributor.authorVurucu, Servan
dc.contributor.authorGüclü, Safiye
dc.date.accessioned2023-03-27T08:17:57Z
dc.date.available2023-03-27T08:17:57Z
dc.date.issued2021en_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractCoronavirus disease 2019 (COVID-19) has caused thousands of deaths since it was declared as a pandemic and continues to be one of the most followed topics in the world in terms of its course and treatment. Favipiravir is a broad-spectrum anti-viral agent that has been shown to be effective against various Coronaviruses in vitro. However, as with any drug use, side effects may develop with the use of favipravir treatment. We aimed to present a case of angioedema and acute urticaria whom had COVID 19 pneumonia, that we cannot distinguish as a rare side effect due to favipiravir treatment or COVID-19 cutaneous manifestation. According to the available literature, this is the first case reported in our country.en_US
dc.identifier.citationAlkan Çeviker, S. , Şener, A. , Yüksel, C. , Önder, T. , Akça, A. , Vurucu, S. & Güçlü, S. (2021). Angioedema and acute urticaria in a patient with COVID 19 pneumonia: Favipiravir side effect or COVID-19 cutaneous manifestation . Journal of Emergency Medicine Case Reports , 12 (2) , 65-67 . DOI: 10.33706/jemcr.851107en_US
dc.identifier.doi10.33706/jemcr.851107
dc.identifier.endpage67en_US
dc.identifier.issn2149-9934
dc.identifier.issue2en_US
dc.identifier.startpage65en_US
dc.identifier.urihttps://doi.org/10.33706/jemcr.851107
dc.identifier.urihttps://hdl.handle.net/20.500.12428/3847
dc.identifier.volume12en_US
dc.identifier.wosWOS:000749551800010
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.institutionauthorÇeviker, Sevil Alkan
dc.institutionauthorŞener, Alper
dc.institutionauthorYüksel, Cihan
dc.institutionauthorÖnder, Taylan
dc.institutionauthorAkça, Anıl
dc.institutionauthorVurucu, Servan
dc.institutionauthorGüçlü, Safiye
dc.language.isoen
dc.publisherEmergency Physicians Association of Turkeyen_US
dc.relation.ispartofJournal of Emergency Medicineen_US
dc.relation.publicationcategoryRaporen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectFavipiraviren_US
dc.subjectSide effecten_US
dc.subjectSARS-CoV-2en_US
dc.subjectCutaneous manifestationsen_US
dc.subjectAngioedemaen_US
dc.subjectAcute urticariaen_US
dc.titleAcute urticaria with Angioedema in a patient with COVID-19 pneumonia: Favipiravir side effect or a rare cutaneous manifestation
dc.typeReport

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Sevil_Alkan_Ceviker_Olgu_Sunumu.pdf
Boyut:
1.02 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Olgu Sunumu
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu